EU ordered more than 100,000 doses of vaccines to deal with monkey acne, Belarus developed monkey acne detection system

The EU Health Emergency Preparation and Reaction Agency signed a procurement contract with the Danish Panana Nordic Corporation on the 14th to plan to purchase about 109,000 doses of the company's third -generation vaccine to deal with the epidemic of the monkey acne. The Belarusian National Popular Science and Microbiology Science and Practice Center said on the 13th that the country has developed a monkey acne virus detection system.

The European Commission issued a bulletin on the 14th that as the number of cases of monkey acne continued to increase, the above contract would ensure that all EU member states and Norway and Iceland obtained vaccines as soon as possible. The Hygiene Emergency Preparation and Reaction Bureau will allocate vaccines to member states in proportion. EU countries with severe epidemics can get vaccines at the end of this month.

EU Council Vice Chairman Margaritis Henas said in a bulletin that this is the first time that the EU budget is used to directly purchase vaccines for member states through the health EU plan. Effective prevention and response to new health threats are our common goals.

Bavaria's third -generation vaccine in the EU is only approved to prevent smallpox in the European Union. Because monkey acne and smallpox belong to the genus acne virus of acne virus, the ceiling vaccine can also protect people from the invasion of monkey acne. Some EU member states have been exempted to allow the vaccine to temporarily use it to prevent monkey acne virus. The European Drug Administration is always preparing to support member states to promote such exemptions, and has contacted Bavarian Nordic companies to accelerate the approval process.

Since May 18, 19 member states in the European Union have reported a total of about 900 cases of acne. At present, the global public health risk of the World Health Organization evaluates monkey acne is "medium".

Gorbnov, Director of the Center of Popular Science and Practice of Microbiology and Microbiology of Belarus, told the media on the 13th that the country's newly developed monkey acne virus detection system uses polymerase chain reaction detection technology, which can be sampled within a few hours after sampling. The results. Gorbinov said that Belarus has not reported to have a case of monkey acne, but it needs to be precautions.

Monkey acne is a kind of viral human and animal disease. Monkey acne virus can be transmitted to people by close contact with animals. Although interpersonal communication is not easy to occur, close contact with the infected person may also be infected. The initial symptoms of human infection of monkey acne include fever, headache, muscle soreness, back pain, lymph nodes, etc., and can be developed into a large range of rash on the face and body. Most infected people will recover within a few weeks, but there are also severe cases of infected people.

(Source: CCTV News)

For more exciting content, please download the "Da Wuhan" client in the major application markets.

- END -